What We Do

Inflection Biosciences' research and development activities are focused on cancer, autoimmune and inflammatory disease. This focus reflects the unmet medical need that exists while also leveraging both the company’s and its extensive research network’s expertise in PIM kinase biology. 

 

Our pipeline is aimed at developing innovative, targeted small molecule therapeutics which address many of those unmet needs.

We have built an international network of universities and research institutes to advance our programs. See Partnerships for further details on collaborations to date.

Inflection Biosciences and RCSI Nov 2017